Cargando…

Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?

OBJECTIVE: Routine measurement of the carotid intima–media thickness is not recommended in recent clinical practice guidelines for risk assessment of the first atherosclerotic cardiovascular disease (ASCVD) event (the definition of which includes acute coronary syndromes, a history of myocardial inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, GeeHee, Youn, Ho-Joong, Choi, Yun-Seok, Jung, Hae Ok, Chung, Wook Sung, Kim, Chul-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500627/
https://www.ncbi.nlm.nih.gov/pubmed/26185430
http://dx.doi.org/10.2147/CIA.S85216
_version_ 1782380946407817216
author Kim, GeeHee
Youn, Ho-Joong
Choi, Yun-Seok
Jung, Hae Ok
Chung, Wook Sung
Kim, Chul-Min
author_facet Kim, GeeHee
Youn, Ho-Joong
Choi, Yun-Seok
Jung, Hae Ok
Chung, Wook Sung
Kim, Chul-Min
author_sort Kim, GeeHee
collection PubMed
description OBJECTIVE: Routine measurement of the carotid intima–media thickness is not recommended in recent clinical practice guidelines for risk assessment of the first atherosclerotic cardiovascular disease (ASCVD) event (the definition of which includes acute coronary syndromes, a history of myocardial infarction, stable or unstable angina, coronary or other arterial revascularization, stroke, transient ischemic attack, or peripheral arterial disease presumed to be of atherosclerotic origin). The aim of the present study was to elucidate the role of carotid artery evaluation for primary prevention of ASCVD in asymptomatic high-risk patients visiting a teaching hospital. METHODS: Eight hundred seventy-three patients (487 male [55.8%], mean age 59.4±11.5 years) who were statin-naive and without ASCVD, which was proven by coronary angiography or coronary CT angiography, were enrolled in this study. The patients underwent carotid scanning in the Medical Department of St Mary’s Hospital from September 2003 to March 2009. ASCVD outcomes were evaluated for median follow-up of 1,402 days. RESULTS: A total of 119 participants experienced ASCVD events. In multivariate Cox regression analysis, age (hazard ratio [HR] =1.026, 95% confidence interval [CI] =1.002–1.050, P=0.033), history of smoking (HR =1.751, 95% CI =1.089–2.815, P=0.021), statin therapy (HR =0.388, 95% CI =0.205–0.734, P=0.004), and carotid plaques (HR =1.556, 95% CI =1.009–2.400, P=0.045) were associated with ASCVD events. In middle-aged group (45≤ age <65, n=473), history of smoking (HR =1.995, 95% CI =1.142–3.485, P=0.015), statin therapy (HR =0.320, 95% CI =0.131–0.780, P=0.012), and carotid plaques (HR =1.993, 95% CI =1.116–3.560, P=0.020) were associated with ASCVD events. CONCLUSION: The presence of carotid plaques, history of smoking, and statin therapy might be important factors for primary prevention of ASCVD in asymptomatic high-risk patients, especially in middle-aged patients. Therefore, the results suggest that carotid artery parameters may have an additional predictive value for primary prevention of ASCVD in the middle-aged high-risk patients.
format Online
Article
Text
id pubmed-4500627
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-45006272015-07-16 Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease? Kim, GeeHee Youn, Ho-Joong Choi, Yun-Seok Jung, Hae Ok Chung, Wook Sung Kim, Chul-Min Clin Interv Aging Original Research OBJECTIVE: Routine measurement of the carotid intima–media thickness is not recommended in recent clinical practice guidelines for risk assessment of the first atherosclerotic cardiovascular disease (ASCVD) event (the definition of which includes acute coronary syndromes, a history of myocardial infarction, stable or unstable angina, coronary or other arterial revascularization, stroke, transient ischemic attack, or peripheral arterial disease presumed to be of atherosclerotic origin). The aim of the present study was to elucidate the role of carotid artery evaluation for primary prevention of ASCVD in asymptomatic high-risk patients visiting a teaching hospital. METHODS: Eight hundred seventy-three patients (487 male [55.8%], mean age 59.4±11.5 years) who were statin-naive and without ASCVD, which was proven by coronary angiography or coronary CT angiography, were enrolled in this study. The patients underwent carotid scanning in the Medical Department of St Mary’s Hospital from September 2003 to March 2009. ASCVD outcomes were evaluated for median follow-up of 1,402 days. RESULTS: A total of 119 participants experienced ASCVD events. In multivariate Cox regression analysis, age (hazard ratio [HR] =1.026, 95% confidence interval [CI] =1.002–1.050, P=0.033), history of smoking (HR =1.751, 95% CI =1.089–2.815, P=0.021), statin therapy (HR =0.388, 95% CI =0.205–0.734, P=0.004), and carotid plaques (HR =1.556, 95% CI =1.009–2.400, P=0.045) were associated with ASCVD events. In middle-aged group (45≤ age <65, n=473), history of smoking (HR =1.995, 95% CI =1.142–3.485, P=0.015), statin therapy (HR =0.320, 95% CI =0.131–0.780, P=0.012), and carotid plaques (HR =1.993, 95% CI =1.116–3.560, P=0.020) were associated with ASCVD events. CONCLUSION: The presence of carotid plaques, history of smoking, and statin therapy might be important factors for primary prevention of ASCVD in asymptomatic high-risk patients, especially in middle-aged patients. Therefore, the results suggest that carotid artery parameters may have an additional predictive value for primary prevention of ASCVD in the middle-aged high-risk patients. Dove Medical Press 2015-07-07 /pmc/articles/PMC4500627/ /pubmed/26185430 http://dx.doi.org/10.2147/CIA.S85216 Text en © 2015 Kim et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Kim, GeeHee
Youn, Ho-Joong
Choi, Yun-Seok
Jung, Hae Ok
Chung, Wook Sung
Kim, Chul-Min
Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
title Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
title_full Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
title_fullStr Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
title_full_unstemmed Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
title_short Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
title_sort is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500627/
https://www.ncbi.nlm.nih.gov/pubmed/26185430
http://dx.doi.org/10.2147/CIA.S85216
work_keys_str_mv AT kimgeehee iscarotidarteryevaluationnecessaryforprimarypreventioninasymptomatichighriskpatientswithoutatheroscleroticcardiovasculardisease
AT younhojoong iscarotidarteryevaluationnecessaryforprimarypreventioninasymptomatichighriskpatientswithoutatheroscleroticcardiovasculardisease
AT choiyunseok iscarotidarteryevaluationnecessaryforprimarypreventioninasymptomatichighriskpatientswithoutatheroscleroticcardiovasculardisease
AT junghaeok iscarotidarteryevaluationnecessaryforprimarypreventioninasymptomatichighriskpatientswithoutatheroscleroticcardiovasculardisease
AT chungwooksung iscarotidarteryevaluationnecessaryforprimarypreventioninasymptomatichighriskpatientswithoutatheroscleroticcardiovasculardisease
AT kimchulmin iscarotidarteryevaluationnecessaryforprimarypreventioninasymptomatichighriskpatientswithoutatheroscleroticcardiovasculardisease